Utah Medical Products, Inc.UTMDNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank36
3Y CAGR-53.5%
5Y CAGR-36.1%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-53.5%/yr
vs +77.9%/yr prior
5Y CAGR
-36.1%/yr
Recent deceleration
Acceleration
-131.4pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.46% |
| Q3 2025 | 0.97% |
| Q2 2025 | -1.40% |
| Q1 2025 | -0.02% |
| Q4 2024 | -5.52% |
| Q3 2024 | -0.26% |
| Q2 2024 | -3.99% |
| Q1 2024 | -0.01% |
| Q4 2023 | 3.21% |
| Q3 2023 | 0.59% |
| Q2 2023 | 2.12% |
| Q1 2023 | 3.15% |
| Q4 2022 | 4.61% |
| Q3 2022 | 1.95% |
| Q2 2022 | -3.05% |
| Q1 2022 | 3.60% |
| Q4 2021 | -3.44% |
| Q3 2021 | 2.53% |
| Q2 2021 | 2.10% |
| Q1 2021 | 2.37% |
| Q4 2020 | 4.36% |
| Q3 2020 | 3.41% |
| Q2 2020 | 0.34% |
| Q1 2020 | -6.01% |
| Q4 2019 | 5.47% |
| Q3 2019 | 0.71% |
| Q2 2019 | -1.61% |
| Q1 2019 | 5.30% |
| Q4 2018 | 0.62% |
| Q3 2018 | 2.17% |
| Q2 2018 | -0.15% |
| Q1 2018 | 4.79% |
| Q4 2017 | 2.28% |
| Q3 2017 | 5.50% |
| Q2 2017 | 4.60% |
| Q1 2017 | 7.29% |
| Q4 2016 | -7.53% |
| Q3 2016 | 2.19% |
| Q2 2016 | -2.61% |
| Q1 2016 | 5.10% |